The cohort study included 8,516 COVID-19 patients treated across 88 Veterans Affairs hospitals between March and August, with a follow up period through November. Results found the adjusted hazard ratio for all-cause mortality was lowest at 0.99 for patients treated when COVID-19 ICU demand was between 25 percent and 50 percent, and highest at 1.94 when the COVID-19 ICU demand was 75 percent to 100 percent.
Results also showed the mortality rate varied over time, with the highest at 25 percent in April and lowest at 12.5 percent in July.
The study did not find an association between COVID-19 ICU load and mortality for COVID-19 patients outside of the ICU.
“Public health officials and hospital administrators may seek to prevent high COVID-19 ICU demand to optimize outcomes for patients with COVID-19,” researchers concluded.
To view the full study, click here.
More articles on patient safety and outcomes:
Rapid blood test helps predict COVID-19 severity, researchers find
Arthritis drugs may reduce deaths for severely ill COVID-19 patients, study finds
76% of hospitalized COVID-19 patients have symptoms for 6 months, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
